EUVIMEDEUVIMED entdecken
Leserbrief

AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit

Masashi Miyaoka, Joaquim Carreras iD, Yara Yukie Kikuti, Haruka Ikoma, Shunsuke Nagase iD, Atsushi Ito iD, Makoto Orita, Yuki Tanigaki, Yohei Masugi, Giovanna Roncador, Naoya Nakamura iD

Pathology International · 2026-07 · 76 (7)

DOI: 10.1111/pin.70145 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pathology International, online erschienen am 05.07.2026. Verfasst von Masashi Miyaoka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Tokai University, Isehara, Japan. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Proto-Oncogene Proteins c-bcl-2, Interferon Regulatory Factors. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseProto-Oncogene Proteins c-bcl-2Interferon Regulatory FactorsHumansProto-Oncogene Proteins c-bcl-6Interferon Regulatory Factor-4PrognosisProto-Oncogene Proteins c-mycBiomarkers, TumorImmunohistochemistry

Substanzen

Proto-Oncogene Proteins c-bcl-6Proto-Oncogene Proteins c-bcl-2Interferon Regulatory Factor-4BCL6 protein, humanInterferon Regulatory FactorsProto-Oncogene Proteins c-mycBiomarkers, TumorBCL2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, School of Medicine, Tokai University, Isehara, Japan.
  • Monoclonal Antibodies Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.

ORCID-Profile: Joaquim Carreras, Shunsuke Nagase, Atsushi Ito, Naoya Nakamura

Zitieren

APA

Miyaoka, M., Carreras, J., Kikuti, Y. Y., Ikoma, H., Nagase, S., Ito, A., Orita, M., Tanigaki, Y., Masugi, Y., Roncador, G., & Nakamura, N. (2026). AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit. Pathology International, 76(7). https://doi.org/10.1111/pin.70145

Vancouver

Miyaoka M, Carreras J, Kikuti YY, Ikoma H, Nagase S, Ito A, et al. AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit. Pathology International. 2026;76(7). doi:10.1111/pin.70145

BibTeX
@article{Miyaoka2026,
  author = {Miyaoka, Masashi and Carreras, Joaquim and Kikuti, Yara Yukie and Ikoma, Haruka and Nagase, Shunsuke and Ito, Atsushi and Orita, Makoto and Tanigaki, Yuki and Masugi, Yohei and Roncador, Giovanna and Nakamura, Naoya},
  title = {AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit},
  journal = {Pathology International},
  year = {2026},
  volume = {76},
  number = {7},
  doi = {10.1111/pin.70145}
}
Kostenlos starten →